References
1. Smolen JS, Aletaha D, McInnes IB.
Rheumatoid arthritis. The Lancet. 2016;388(10055):2023-38.
2. Tilstra JS, Lienesch DW. Rheumatoid
nodules. Dermatologic clinics. 2015;33(3):361-71.
3. Jagadeesan S, Shenoy P. Arthropathy
in dermatology: A comprehensive review. Indian dermatology online
journal. 2017;8(2):79.
4. Levin J, Werth VP. Skin disorders
with arthritis. Best Practice & Research Clinical Rheumatology.
2006;20(4):809-26.
5. Paget SA. Rheumatoid arthritis (RA)
is a chronic systemic autoimmune and in-flammatory disorder of unclear
etiology. It is characterized by a sym-metric polyarthritis, which is
often erosive, resulting in irreversible damage to the joints. Although
the musculoskeletal manifestations usually dominate the clinical
picture, extra-articular manifestations are also common and on rare
occasions can be life-threatening. RA is the most common immune-mediated
inflammatory arthropathy, with a prevalence of up to 1.5% in North
America. In some Native-American populations, the preva-lence may exceed
5%. Expert Guide to Rheumatology. 2005:29.
6. Akdeniz N, Çalka Ö, Bilgili SG,
Bayram İ. A Case of Rheumatoid Neutrophilic Dermatosis. Journal of the
Turkish Academy of Dermatology. 2008;2(4).
7. Lazarov A, Mor A, Cordoba M, Mekori
YA. Rheumatoid neutrophilic dermatitis: an initial dermatological
manifestation of seronegative rheumatoid arthritis. Journal of the
European Academy of Dermatology and Venereology : JEADV. 2002
Jan;16(1):74-6. PubMed PMID: 11952297.
8. Chua-Aguilera CJ, Möller B,
Yawalkar N. Skin manifestations of rheumatoid arthritis, juvenile
idiopathic arthritis, and spondyloarthritides. Clinical reviews in
allergy & immunology. 2017;53(3):371-93.
9. Hata T, Kavanaugh A. Rheumatoid
arthritis in dermatology. Clinics in dermatology. 2006;24(5):430-7.
10. Bevin AA, Steger J, Mannino S.
Rheumatoid neutrophilic dermatitis. Cutis. 2006 Aug;78(2):133-6. PubMed
PMID: 16983904.
11. Lee HH, Song IH, Friedrich M,
Gauliard A, Detert J, Röwert J, et al. Cutaneous side‐effects in
patients with rheumatic diseases during application of tumour necrosis
factor‐α antagonists. British Journal of Dermatology.
2007;156(3):486-91.
12. Marcucci E, Bartoloni E, Alunno
A, Leone M, Cafaro G, Luccioli F, et al. Extra-articular rheumatoid
arthritis. Reumatismo. 2018;70(4):212-24.
13. MATSUSHITA M, YAMAJI K, TAMURA N.
Extra-articular Manifestations of Rheumatoid Arthritis. Juntendo Medical
Journal. 2020;66(1):21-6.
14. Zuk G, Jaworecka K, Samotij D,
Ostanska E, Reich A. Rheumatoid neutrophilic dermatitis. Reumatologia.
2019;57(6):350-3. PubMed PMID: 32226170. Pubmed Central PMCID: 7091481.
15. Below J, Helbig D. [Rheumatoid
neutrophilic dermatitis]. Der Hautarzt; Zeitschrift fur Dermatologie,
Venerologie, und verwandte Gebiete. 2015 Apr;66(4):228-30. PubMed PMID:
25757837. Rheumatoide neutrophile Dermatitis.
16. Ergun T, Inanc N, Tuney D,
Kotiloglu EK, Seckin D, Tetik C, et al. Skin manifestations of
rheumatoid arthritis: a study of 215 Turkish patients. International
journal of dermatology. 2008;47(9):894-902.
17. Alavi A, Sajic D, Cerci FB,
Ghazarian D, Rosenbach M, Jorizzo J. Neutrophilic dermatoses: an update.
American journal of clinical dermatology. 2014;15(5):413-23.
18. Çetin GY, Sayarlıoğlu H, Erhan Ç,
Kahraman H, Cıralık H, Sayarlıoğlu M. A case of neutrophilic dermatosis
who develop palpable purpura during the use of montelukast. European
journal of rheumatology. 2014;1(4):170.
19. Kumari I, Dongre A, Mohanty S.
Rheumatoid Neutrophilic Dermatosis: The Distinct Entity with Florid
Presentation. Indian dermatology online journal. 2020
Jan-Feb;11(1):114-5. PubMed PMID: 32055526. Pubmed Central PMCID:
7001406.
20. Wijenayake BK. Neutrophilic
Dermatoses. Atlas of Dermatoses in Pigmented Skin: Springer; 2021. p.
213-23.